Stifel Financial Corp
12 nominees · 5 ballot items.
Election of twelve directors; an advisory vote to approve executive compensation (say-on-pay); approval to amend the Certificate of Incorporation to increase authorized common shares by 50%; authorization to increase the 2001 Incentive Stock Plan capacity by 9,000,000 shares (including 175,000 for non-employee directors); and ratification of KPMG LLP as independent auditor for 2026.
Follow how the vote landed and what changed on Stifel Financial Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot5
- 1
Election of Directors
ManagementBoard: FORElection of twelve director nominees to the Board for one-year terms.
- 2
Advisory Vote to Approve Executive Compensation (Say on Pay
ManagementBoard: FORNon-binding, advisory vote to approve the compensation of the named executive officers as disclosed in the proxy statement.
More detail
This advisory proposal asks shareholders to cast a non-binding vote to approve the Company’s executive compensation program as disclosed in the proxy, including the Compensation Discussion & Analysis and compensation tables. Management seeks this advisory approval to confirm shareholder support for the Committee’s pay decisions and to provide feedback that the Compensation Committee will consider in future determinations. The proposal is routine under Dodd-Frank Section 14A and is presented annually; the Board has recommended an annual frequency and is asking for approval of the 2025 compensation practices. Contextually, Stifel reports strong financial performance in 2025, continued use of performance-based restricted stock units (PRSUs) measured over multi-year periods, and a pay mix that emphasizes retention and alignment via equity and deferred awards. The Compensation Committee emphasizes long-term alignment and risk controls, including PRSU metrics (Relative TSR, non-GAAP EPS, and non-GAAP ROCE) and uses non-GAAP measures to assess multiyear performance. Management’s justification emphasizes shareholder outreach, high historical advisory support, and governance features such as clawbacks, double-trigger vesting, and use of an independent compensation consultant. A vote FOR signals investor acceptance of the Committee’s pay philosophy and program design; a vote AGAINST would be advisory but could trigger further engagement and potential changes to program features. The Board’s recommendation is FOR because the Committee believes the compensation structure aligns management incentives with long-term shareholder value while incorporating controls to mitigate excessive risk-taking.
- 3
Adoption of an Amendment to the Company’s Certificate of Incorporation to Increase Authorized Common Shares by 50%
ManagementBoard: FORAmend the Certificate of Incorporation to increase total authorized shares from 197,000,000 to 294,000,000 and authorized common shares from 194,000,000 to 291,000,000 (a 50% increase).
More detail
This management proposal requests shareholder approval to amend the Company’s Certificate of Incorporation to increase authorized shares by 50%, raising total authorized shares to 294 million and common shares to 291 million. Management argues the increase creates a reserve to enable issuance for corporate purposes—stock dividends, stock splits, financings, acquisitions, and employee benefit plans—without the need for further shareholder votes, providing strategic flexibility. At the record date the company had ~153.8 million shares outstanding, representing about 79% of currently authorized common shares, which underscores the Board’s stated rationale for increasing the authorization. The board discloses the potential dilutive effect but frames the change as prudent corporate governance to preserve optionality for transactions and capital management. From a governance standpoint, shareholders should weigh the benefits of operational flexibility and deal execution speed against the long-term dilution risk and potential for increased insider ability to issue shares. Management mitigates concerns by noting that additional shares would have identical rights to current common shares and that issuance would remain subject to applicable law and exchange rules; the filing also references historical share repurchases and dilution controls. A FOR vote signals shareholder support for preserving strategic flexibility; a AGAINST vote would reflect concerns about dilution and stewardship of share capital. The Board’s recommendation FOR is based on balancing the need for available shares for routine corporate and strategic uses against the risk of dilution to existing shareholders.
- 4
Authorization to Increase 2001 Incentive Stock Plan Capacity by 9,000,000 Shares (including 175,000 for non-employee directors
ManagementBoard: FORAuthorize amendments to the 2001 Incentive Stock Plan (2018 Restatement) to increase available share capacity by 9,000,000 shares, of which 175,000 would be reserved for non-employee directors.
More detail
Management seeks shareholder authorization to add 9,000,000 shares to the Company’s long-standing equity incentive plan to preserve the firm’s ability to grant RSUs, PRSUs, and other awards used broadly across ~8,000 participating associates and to support hiring and acquisition-related retention. The filing explains that the Plan is integral to the Company’s compensation philosophy—aligning employees with shareholders and substituting equity for cash where appropriate—so the requested increase is argued as a change in form, not magnitude, of compensation. The proxy provides utilization history (gross grants for 2023–2025 and net shares issued), current available shares (~4.5 million) and estimated annual utilization (~1.375 million), supporting management’s claim that an additional 9 million shares is needed to accommodate future grants and potential acquisition-related awards. Management also details dilution controls—limits on grant sizes, net settlement, and share repurchases—and notes that on a net basis repurchases and cash settlements have offset gross issuance. The filing addresses ISS’s shareholder value transfer (SVT) metric and argues the SVT underweights retention-focused longer vesting schedules and ignores cash compensation, making the metric imperfect for judging the request. Shareholders should consider the tradeoff between dilution on a gross basis and retention/hiring benefits that management ties to long-term shareholder value creation. The Board’s recommendation FOR is premised on the Plan’s role in talent and acquisition strategy, the historical disciplined usage of the Plan, and the described governance safeguards; a negative vote would constrain grant flexibility and could require more cash compensation or limit retention tools.
- 5
Ratification of Appointment of Independent Registered Public Accounting Firm (KPMG LLP
ManagementBoard: FORRatify the Audit Committee’s selection of KPMG LLP as the Company’s independent registered public accounting firm for 2026.
Nominees on the ballot12
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 5.6% | 8,521,859 | $630M |
| 2 | AQR CAPITAL MANAGEMENT LLC | 5.5% | 8,414,543 | $618M |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.6% | 7,123,755 | $527M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 4.3% | 6,647,564 | $491M |
| 5 | FMR LLC | 4.0% | 6,111,932 | $452M |
| 6 | STATE STREET CORP | 3.0% | 4,652,555 | $344M |
| 7 | BlackRock, Inc. | 2.9% | 4,473,201 | $331M |
| 8 | Boston Partners | 2.6% | 3,933,731 | $291M |
| 9 | STIFEL FINANCIAL CORP | 2.5% | 3,763,992 | $278M |
| 10 | EARNEST PARTNERS LLC | 2.4% | 3,690,114 | $273M |
Other Financial Services sector meetings6
Upcoming shareholder meetings at Stifel Financial Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Stifel Financial Corp 2026 annual meeting?
- Stifel Financial Corp (SF) holds its 2026 annual shareholder meeting on Tuesday, June 9, 2026.
- What is the record date for the Stifel Financial Corp 2026 meeting?
- The record date for the Stifel Financial Corp 2026 meeting is Monday, April 13, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Stifel Financial Corp's 2026 meeting?
- The board is presenting 12 director nominees at the Stifel Financial Corp 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Stifel Financial Corp 2026 meeting?
- Shareholders will vote on 5 proposals at the Stifel Financial Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.